{"id":25010,"date":"2024-07-25T08:37:03","date_gmt":"2024-07-25T06:37:03","guid":{"rendered":"https:\/\/projects.leitat.org\/home\/?p=25010"},"modified":"2025-02-05T20:25:50","modified_gmt":"2025-02-05T20:25:50","slug":"proyecto-modern","status":"publish","type":"post","link":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/","title":{"rendered":"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas"},"content":{"rendered":"\r\n<p>Las enfermedades neurol\u00f3gicas, en su mayor\u00eda, tienen su origen en alteraciones en la expresi\u00f3n g\u00e9nica, regulada por mecanismos epigen\u00e9ticos dentro de las c\u00e9lulas neuronales. Sin embargo, este campo sigue siendo uno de los menos explorados en t\u00e9rminos terap\u00e9uticos, con una falta de f\u00e1rmacos espec\u00edficos disponibles actualmente.<\/p>\r\n\r\n\r\n\r\n<p>En el proyecto MODERN, la farmac\u00e9utica Oryzon, la Universidad Aut\u00f2noma de Barcelona, el Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge y Leitat se unen con el prop\u00f3sito de descubrir y validar un nuevo inhibidor epigen\u00e9tico para el tratamiento de alteraciones neurol\u00f3gicas en humanos. El objetivo es identificar un mecanismo epigen\u00e9tico innovador que pueda servir como nueva diana terap\u00e9utica.<\/p>\r\n\r\n\r\n\r\n<p>El proyecto comenzar\u00e1 con la selecci\u00f3n de muestras de pacientes con alteraciones gen\u00e9ticas espec\u00edficas, donde se identificar\u00e1n los marcadores epigen\u00e9ticos relevantes. Posteriormente, se desarrollar\u00e1n modelos in vivo e in vitro para caracterizar y optimizar los nuevos compuestos descubiertos.<\/p>\r\n\r\n\r\n\r\n<p>MODERN representa un significativo avance en la investigaci\u00f3n de la epigen\u00e9tica aplicada a las enfermedades neurol\u00f3gicas, acelerando el descubrimiento de nuevas dianas terap\u00e9uticas y facilitando el desarrollo de tratamientos efectivos.<\/p>\r\n\r\n\r\n\r\n<p>Proyecto CPP2022-009550 financiado por:<\/p>\r\n\r\n\r\n\r\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" width=\"387\" height=\"71\" class=\"wp-image-25007\" style=\"width: 308px; height: auto;\" src=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/Imagen1.png\" alt=\"\" srcset=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/Imagen1.png 387w, https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/Imagen1-300x55.png 300w\" sizes=\"(max-width: 387px) 100vw, 387px\" \/><\/figure>\r\n","protected":false},"excerpt":{"rendered":"<p>Las enfermedades neurol\u00f3gicas, en su mayor\u00eda, tienen su origen en alteraciones en la expresi\u00f3n g\u00e9nica, regulada por mecanismos epigen\u00e9ticos dentro de las c\u00e9lulas neuronales. Sin embargo, este campo sigue siendo uno de los menos explorados en t\u00e9rminos terap\u00e9uticos, con una falta de f\u00e1rmacos espec\u00edficos disponibles actualmente. En el proyecto MODERN, la farmac\u00e9utica Oryzon, la Universidad [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":25021,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[13,14],"tags":[],"class_list":["post-25010","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aei","category-health-technologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas - Leitat Technological Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas - Leitat Technological Center\" \/>\n<meta property=\"og:description\" content=\"Las enfermedades neurol\u00f3gicas, en su mayor\u00eda, tienen su origen en alteraciones en la expresi\u00f3n g\u00e9nica, regulada por mecanismos epigen\u00e9ticos dentro de las c\u00e9lulas neuronales. Sin embargo, este campo sigue siendo uno de los menos explorados en t\u00e9rminos terap\u00e9uticos, con una falta de f\u00e1rmacos espec\u00edficos disponibles actualmente. En el proyecto MODERN, la farmac\u00e9utica Oryzon, la Universidad [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/\" \/>\n<meta property=\"og:site_name\" content=\"Leitat Technological Center\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-25T06:37:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T20:25:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dissemination Manager\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dissemination Manager\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/\"},\"author\":{\"name\":\"Dissemination Manager\",\"@id\":\"https:\/\/leitat.org\/es\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2\"},\"headline\":\"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas\",\"datePublished\":\"2024-07-25T06:37:03+00:00\",\"dateModified\":\"2025-02-05T20:25:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/\"},\"wordCount\":219,\"publisher\":{\"@id\":\"https:\/\/leitat.org\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg\",\"articleSection\":[\"AEI\",\"Health technologies\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/\",\"url\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/\",\"name\":\"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas - Leitat Technological Center\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg\",\"datePublished\":\"2024-07-25T06:37:03+00:00\",\"dateModified\":\"2025-02-05T20:25:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#primaryimage\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"HOME\",\"item\":\"https:\/\/leitat.org\/es\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AEI\",\"item\":\"https:\/\/leitat.org\/es\/blog\/category\/aei\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/leitat.org\/es\/#website\",\"url\":\"https:\/\/leitat.org\/es\/\",\"name\":\"Leitat Technological Center\",\"description\":\"Managing Technologies\",\"publisher\":{\"@id\":\"https:\/\/leitat.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/leitat.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/leitat.org\/es\/#organization\",\"name\":\"Leitat Technological Center\",\"url\":\"https:\/\/leitat.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/leitat.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"width\":226,\"height\":78,\"caption\":\"Leitat Technological Center\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/leitat.org\/es\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2\",\"name\":\"Dissemination Manager\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g\",\"caption\":\"Dissemination Manager\"},\"sameAs\":[\"https:\/\/leitat.org\"],\"url\":\"https:\/\/leitat.org\/es\/blog\/author\/editor-wp\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas - Leitat Technological Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_ES","og_type":"article","og_title":"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas - Leitat Technological Center","og_description":"Las enfermedades neurol\u00f3gicas, en su mayor\u00eda, tienen su origen en alteraciones en la expresi\u00f3n g\u00e9nica, regulada por mecanismos epigen\u00e9ticos dentro de las c\u00e9lulas neuronales. Sin embargo, este campo sigue siendo uno de los menos explorados en t\u00e9rminos terap\u00e9uticos, con una falta de f\u00e1rmacos espec\u00edficos disponibles actualmente. En el proyecto MODERN, la farmac\u00e9utica Oryzon, la Universidad [&hellip;]","og_url":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/","og_site_name":"Leitat Technological Center","article_published_time":"2024-07-25T06:37:03+00:00","article_modified_time":"2025-02-05T20:25:50+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg","type":"image\/jpeg"}],"author":"Dissemination Manager","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Dissemination Manager","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#article","isPartOf":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/"},"author":{"name":"Dissemination Manager","@id":"https:\/\/leitat.org\/es\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2"},"headline":"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas","datePublished":"2024-07-25T06:37:03+00:00","dateModified":"2025-02-05T20:25:50+00:00","mainEntityOfPage":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/"},"wordCount":219,"publisher":{"@id":"https:\/\/leitat.org\/es\/#organization"},"image":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg","articleSection":["AEI","Health technologies"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/","url":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/","name":"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas - Leitat Technological Center","isPartOf":{"@id":"https:\/\/leitat.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#primaryimage"},"image":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg","datePublished":"2024-07-25T06:37:03+00:00","dateModified":"2025-02-05T20:25:50+00:00","breadcrumb":{"@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leitat.org\/es\/blog\/proyecto-modern\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#primaryimage","url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/leitat.org\/es\/blog\/proyecto-modern\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"HOME","item":"https:\/\/leitat.org\/es\/home\/"},{"@type":"ListItem","position":2,"name":"AEI","item":"https:\/\/leitat.org\/es\/blog\/category\/aei\/"},{"@type":"ListItem","position":3,"name":"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas"}]},{"@type":"WebSite","@id":"https:\/\/leitat.org\/es\/#website","url":"https:\/\/leitat.org\/es\/","name":"Leitat Technological Center","description":"Managing Technologies","publisher":{"@id":"https:\/\/leitat.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leitat.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/leitat.org\/es\/#organization","name":"Leitat Technological Center","url":"https:\/\/leitat.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/leitat.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","width":226,"height":78,"caption":"Leitat Technological Center"},"image":{"@id":"https:\/\/leitat.org\/es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/leitat.org\/es\/#\/schema\/person\/00bc0fc5cc4e098e7d903185a43a9ca2","name":"Dissemination Manager","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/27a953619ddefc600b35a23a2d9ef2e36fdefa6d9e76db6809a834bcd5a811ea?s=96&d=mm&r=g","caption":"Dissemination Manager"},"sameAs":["https:\/\/leitat.org"],"url":"https:\/\/leitat.org\/es\/blog\/author\/editor-wp\/"}]}},"_links":{"self":[{"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/posts\/25010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/comments?post=25010"}],"version-history":[{"count":1,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/posts\/25010\/revisions"}],"predecessor-version":[{"id":61640,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/posts\/25010\/revisions\/61640"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/media\/25021"}],"wp:attachment":[{"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/media?parent=25010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/categories?post=25010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leitat.org\/es\/wp-json\/wp\/v2\/tags?post=25010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}